Skanska Beats Forecast, but 2010 Still Gloomy

Eric Marshall, of Hodges Capital Management, shares his favorite small cap plays.

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

CNBC's Scott Cohn takes a look at the modern day gold rush.

Heinz profit fell 16 percent, but the company beat analyst estimates on emerging-market growth. William Johnson, chairman and CEO of Heinz, talks to CNBC.